ArticleCancers2024

Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma.

Andrea Duminuco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.